Trevi Therapeutics (TRVI) Net Equity Issued and Repurchased (2018 - 2026)
Trevi Therapeutics' Net Equity Issued and Repurchased came in at $1.72 million for Q2 2026, down 32.2% from $2.54 million a year earlier but up 675.2% from the prior quarter.
Powered by 
Analysis
Trevi Therapeutics (TRVI) Net Equity Issued and Repurchased (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Trevi Therapeutics reported Net Equity Issued and Repurchased of $1.94 million, down 82.2% year-over-year; for FY2025, it came in at $10.76 million.
- Net Equity Issued and Repurchased carries a five-year compound annual growth rate of 216.3% (FY2020 to FY2025).
- Going back by year, Net Equity Issued and Repurchased was $394,000 in FY2024 (+432.4%), $74,000 in FY2023 (-99.9%), $105.41 million in FY2022 (+670.7%) and $13.68 million in FY2021.
- The five-year range for quarterly Net Equity Issued and Repurchased is $1,000 (Q4 2023) to $51.82 million (Q2 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Trevi Therapeutics | 2.04 Bn | 2.04 Bn | - | 1.72 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.72 Mn |
| Mar 31, 2026 | 222,000.00 |
| Jun 30, 2025 | 2.54 Mn |
| Mar 31, 2025 | 8.22 Mn |
| Dec 31, 2024 | 13,000.00 |
| Sep 30, 2024 | 163,000.00 |
| Jun 30, 2024 | 214,000.00 |
| Mar 31, 2024 | 4,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | 3,000.00 |
| Jun 30, 2023 | 8,000.00 |
| Mar 31, 2023 | 62,000.00 |
| Dec 31, 2022 | 2.40 Mn |
| Sep 30, 2022 | 51.18 Mn |
| Jun 30, 2022 | 51.82 Mn |
| Mar 31, 2022 | 2,000.00 |
| Dec 31, 2021 | 13.66 Mn |
| Sep 30, 2020 | 7,000.00 |
| Jun 30, 2019 | 41.19 Mn |
| Mar 31, 2019 | 9.96 Mn |
API Access
Trevi Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=TRVI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "TRVI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=TRVI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();